SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes
出版年份 2022 全文链接
标题
SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes
作者
关键词
Diabetes mellitus, Fibrosis, Cardiovascular diseases, Heart, Inflammation, Atherosclerosis, Blood pressure, Analysis of variance
出版物
PLoS One
Volume 17, Issue 2, Pages e0263285
出版商
Public Library of Science (PLoS)
发表日期
2022-02-18
DOI
10.1371/journal.pone.0263285
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study
- (2020) Naoto Katakami et al. Cardiovascular Diabetology
- Empagliflozin protects heart from inflammation and energy depletion via AMPK activation
- (2020) Chintan N. Koyani et al. PHARMACOLOGICAL RESEARCH
- SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
- (2019) Chenguang Li et al. Cardiovascular Diabetology
- Cardiovascular Risk in Type 1 Diabetes Mellitus
- (2019) Jonathan Schofield et al. Diabetes Therapy
- Direct effects of empagliflozin on extracellular matrix remodeling in human cardiac myofibroblasts: Novel translational clues to EMPA-REG OUTCOME
- (2019) Sean Kang et al. CANADIAN JOURNAL OF CARDIOLOGY
- Effect of ipragliflozin, an SGLT2 inhibitor, on cardiac histopathological changes in a non-diabetic rat model of cardiomyopathy
- (2019) Toshiyuki Takasu et al. LIFE SCIENCES
- Klotho inhibits PKCα/p66SHC-mediated podocyte injury in diabetic nephropathy
- (2019) Wei Jiang et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Natural History of Atherosclerosis and Abdominal Aortic Intima-Media Thickness: Rationale, Evidence, and Best Practice for Detection of Atherosclerosis in the Young
- (2019) Michael R. Skilton et al. Journal of Clinical Medicine
- Klotho improves diabetic cardiomyopathy by suppressing the NLRP3 inflammasome pathway
- (2019) Xuelian Li et al. LIFE SCIENCES
- Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats
- (2019) Alana Aragón-Herrera et al. BIOCHEMICAL PHARMACOLOGY
- Klotho protects the heart from hyperglycemia-induced injury by inactivating ROS and NF-κB-mediated inflammation both in vitro and in vivo
- (2018) Yue Guo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Empagliflozin influences blood viscosity and wall shear stress in subjects with type 2 diabetes mellitus compared with incretin-based therapy
- (2018) Concetta Irace et al. Cardiovascular Diabetology
- Diabetic Cardiomyopathy
- (2018) Guanghong Jia et al. CIRCULATION RESEARCH
- Efficacy and safety of sodium–glucose cotransporter 2 inhibitor ipragliflozin on glycemic control and cardiovascular parameters in Japanese patients with type 2 diabetes mellitus; Fukuoka Study of Ipragliflozin (FUSION)
- (2018) Takashi Nomiyama et al. ENDOCRINE JOURNAL
- Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice
- (2018) Νarjes Nasiri-Ansari et al. Cardiovascular Diabetology
- Empagliflozin, SGLT2 inhibitor, attenuates renal fibrosis in rats exposed to unilateral ureteric obstruction: potential role of klotho expression
- (2018) Noha A. T. Abbas et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Exogenous Pancreatic Kallikrein Improves Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetes
- (2018) Meng Wu et al. Frontiers in Pharmacology
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Animal models of atherosclerosis
- (2017) Besa Emini Veseli et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts
- (2017) Tsung-Ming Lee et al. FREE RADICAL BIOLOGY AND MEDICINE
- Serum klotho protein levels and their correlations with the progression of type 2 diabetes mellitus
- (2017) Fang Nie et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Effects of Canagliflozin on Cardiovascular Biomarkers in Older Adults With Type 2 Diabetes
- (2017) James L. Januzzi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Role of B‐Type Natriuretic Peptide and N‐Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus
- (2017) Emil Wolsk et al. Journal of the American Heart Association
- Left ventricular pressure-volume measurements and myocardial gene expression profile in type 2 diabetic Goto-Kakizaki rats
- (2016) Sevil Korkmaz-Icöz et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome
- (2016) Hiroaki Kusaka et al. Cardiovascular Diabetology
- Clinical Update: Cardiovascular Disease in Diabetes Mellitus
- (2016) Cecilia C. Low Wang et al. CIRCULATION
- Association of Cardiovascular Risk Factors and Myocardial Fibrosis With Early Cardiac Dysfunction in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study
- (2016) Anderson C. Armstrong et al. DIABETES CARE
- Sodium-glucose co-transporter-2 inhibitors suppress atrial natriuretic peptide secretion in patients with newly diagnosed Type 2 diabetes
- (2016) Y. Wang et al. DIABETIC MEDICINE
- Innate Immunity and the Failing Heart
- (2015) Douglas L. Mann CIRCULATION RESEARCH
- Low Serum Level of Klotho Is an Early Predictor of Atherosclerosis
- (2015) Nursen Keles et al. TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE
- Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored
- (2014) John J V McMurray et al. Lancet Diabetes & Endocrinology
- Early cardiac changes in a rat model of prediabetes: brain natriuretic peptide overexpression seems to be the best marker
- (2013) Sara Nunes et al. Cardiovascular Diabetology
- Anti-inflammatory effects of triptolide improve left ventricular function in a rat model of diabetic cardiomyopathy
- (2013) He-Ling Wen et al. Cardiovascular Diabetology
- Analytical Characteristics of High-Sensitivity Cardiac Troponin Assays
- (2011) F. S. Apple et al. CLINICAL CHEMISTRY
- Plasma Klotho and Cardiovascular Disease in Adults
- (2011) Richard D. Semba et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Glycaemic control and incidence of heart failure in 20 985 patients with type 1 diabetes: an observational study
- (2011) Marcus Lind et al. LANCET
- Elevated plasma levels of TNF-alpha and Interleukin-6 in patients with diastolic dysfunction and glucose metabolism disorders
- (2009) Wilfried Dinh et al. Cardiovascular Diabetology
- Arterial stiffness, carotid artery intima-media thickness and plasma myeloperoxidase level in children with type 1 diabetes
- (2009) Kaire Heilman et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Aortic Intima Media Thickness is an Early Marker of Atherosclerosis in Children with Type 1 Diabetes Mellitus
- (2009) Jennifer Harrington et al. JOURNAL OF PEDIATRICS
- Progression and Disruption of Advanced Atherosclerotic Plaques in Murine Models
- (2008) Michael Rosenfeld et al. CURRENT DRUG TARGETS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started